Kevin Young's Net Worth

$67 Million

Estimate Recalculated Nov 8, 2024 09:31PM EST

Who is Kevin Young

Kevin Young has an estimated net worth of $67 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, and Cortexyme, Inc..

SEC CIK

Kevin Young's CIK is 0001303643

Past Insider Trading and Trends

2009 was Kevin Young's most active year for acquiring shares with 12 total transactions. Kevin Young's most active month to acquire stocks was the month of December. 2007 was Kevin Young's most active year for disposing of shares, totalling 38 transactions. Kevin Young's most active month to dispose stocks was the month of January. 2012 saw Kevin Young paying a total of $12,233,356.89 for 578,579 shares, this is the most they've acquired in one year. In 2012 Kevin Young cashed out on 931,722 shares for a total of $34,745,487.10, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GILEAD SCIENCES INC

Chief Operating Officer

Updated Feb 23, 2018

View Quote Details


Form 4	61.98%	9.80K	$62.35	$21.20K	Feb 23, 2018	25.61K	Grant	—	Feb 15 - Feb 21
Form 4	-2.19%	-425.00	$79.32	-$33.71K	Feb 13, 2018	19.00K	Options	—	Feb 10
Form 4	31.33%	4.63K	$83.77	-$207.51K	Feb 02, 2018	19.42K	Options	—	Jan 31 - Feb 01
Form 4	50.66%	3.39K	$73.02	-$249.87K	Nov 13, 2017	10.08K	Grant	—	Nov 09
Form 4	-3.82%	-453.00	$72.70	-$32.93K	Aug 14, 2017	11.40K	Options	—	Aug 10
Form 4	116.28%	3.35K	$66.92	-$231.54K	May 12, 2017	6.23K	Grant	—	May 10
Form 4	12.28%	315.00	$59.33	$18.69K	Feb 21, 2017	2.88K	Grant	—	Feb 15
Form 4	-3.73%	-317.00	$66.36	-$21.04K	Feb 14, 2017	8.19K	Options	—	Feb 10
Form 4	—	115.87K	$72.25	$8.37M	Feb 06, 2017	115.87K	Grant	—	Feb 02
Form 4	-2.47%	-215.00	$72.82	-$15.66K	Feb 03, 2017	8.51K	Options	—	Feb 01
Form 4	—	83.88K	—	—	Jun 14, 2016	83.88K	Grant	—	Jun 10
Form 3	—	—	—	—	May 31, 2016	1.13K	—	—	—
Form 4	-0.24%	-400.00	—	—	Feb 04, 2014	164.66K	Disposition	—	Feb 01
Form 4	-23.59%	-100.00K	$48.92	-$6.50M	Jan 27, 2014	323.93K	Sale	Scheduled	Jan 23
Form 4	18.15%	33.25K	—	—	Jan 27, 2014	216.42K	Grant	—	Jan 23
Form 4	-16.88%	-75.00K	$45.30	-$4.33M	Dec 24, 2013	369.35K	Sale	Scheduled	Dec 20
Form 4	-14.44%	-75.00K	$45.37	-$4.35M	Nov 25, 2013	444.35K	Sale	Scheduled	Nov 22
Form 4	-12.62%	-75.00K	$42.48	-$3.91M	Oct 25, 2013	519.35K	Sale	Scheduled	Oct 23
Form 4	-14.40%	-100.00K	$39.12	-$4.75M	Sep 25, 2013	594.35K	Sale	Scheduled	Sep 23
Form 4	9.37%	13.87K	$45.40	-$686.99K	Mar 08, 2013	161.84K	Grant	—	Mar 06
Form 4	-50.00%	-108.47K	—	—	Feb 05, 2013	108.47K	Grant	—	Feb 01
Form 4	-86.24%	-460.75K	$50.45	-$22.06M	Nov 20, 2012	73.50K	Sale	—	Nov 16 - Nov 19
Form 4	1.01%	733.00	$29.02	$21.27K	Jul 03, 2012	73.50K	Grant	—	Jun 29
Form 4	21.49%	12.87K	$46.16	-$472.22K	Mar 14, 2012	72.77K	Grant	—	Mar 12
Form 4	—	94.00K	—	—	Jan 30, 2012	94.00K	Grant	—	Jan 26
Form 4	—	—	—	—	Dec 22, 2011	59.90K	—	—	—
Form 4/A	29.07%	13.33K	$39.79	-$394.88K	Apr 06, 2011	59.17K	Grant	—	Mar 15
Form 4	24.56%	11.26K	$39.79	-$322.90K	Mar 17, 2011	57.10K	Grant	—	Mar 15
Form 4	—	119.00K	—	—	Jan 24, 2011	119.00K	Grant	—	Jan 20
Form 4	—	—	$17.68	$176.75K	Aug 26, 2010	117.72K	Options	—	Aug 24
Form 4	73.31%	14.92K	$47.01	-$521.01K	Mar 10, 2010	35.26K	Grant	—	Mar 08
Form 4	—	87.00K	—	—	Feb 01, 2010	87.00K	Grant	—	Jan 28
Form 4	-40.88%	-75.00K	$31.26	-$2.18M	Dec 03, 2009	108.48K	Sale	—	Dec 01
Form 4	-14.05%	-30.00K	$30.91	-$827.50K	Oct 07, 2009	183.48K	Sale	—	Oct 05
Form 4	-18.18%	-30.00K	$30.88	-$825.39K	Jul 10, 2009	135.05K	Sale	—	Jul 09
Form 4	-10.99%	-30.00K	$32.27	-$908.72K	Apr 07, 2009	243.00K	Sale	—	Apr 03
Form 4	55.02%	7.05K	$44.04	-$261.95K	Mar 16, 2009	19.87K	Grant	—	Mar 12
Form 4	—	92.40K	—	—	Jan 23, 2009	92.40K	Grant	—	Jan 21
Form 4	-10.14%	-30.00K	$33.49	-$982.14K	Jan 08, 2009	265.95K	Sale	—	Jan 07
Form 4/A	-70.07%	-30.00K	$45.51	-$1.37M	Oct 14, 2008	12.82K	Sale	—	Oct 06
Form 4	-9.20%	-30.00K	$31.29	-$849.93K	Oct 08, 2008	295.95K	Sale	—	Oct 06
Form 4	-8.43%	-30.00K	$34.46	-$1.04M	Jul 10, 2008	325.95K	Sale	—	Jul 08
Form 4	-7.79%	-30.00K	$34.32	-$1.03M	Apr 14, 2008	355.15K	Sale	—	Apr 10
Form 4	153.72%	7.29K	$47.55	-$271.75K	Mar 19, 2008	12.02K	Grant	—	Mar 17
Form 4	—	140.00K	—	—	Feb 01, 2008	140.00K	Grant	—	Jan 30
Form 4	-7.36%	-30.00K	$31.95	-$889.88K	Jan 09, 2008	377.87K	Sale	—	Jan 07
Form 4	-6.85%	-30.00K	$29.35	-$733.61K	Oct 10, 2007	407.81K	Sale	Scheduled	Oct 09
Form 4	-6.41%	-30.00K	$28.24	-$667.25K	Jul 06, 2007	437.81K	Sale	Scheduled	Jul 03
Form 4	—	35.00K	—	—	May 10, 2007	35.00K	Grant	—	May 08
Form 4	-11.38%	-30.00K	$53.27	-$1.14M	Feb 22, 2007	233.54K	Sale	—	Feb 20
Form 4	—	130.00K	—	—	Jan 24, 2007	130.00K	Grant	—	Jan 22
Form 4	-21.83%	-24.00K	$47.02	-$719.97K	Aug 11, 2006	85.92K	Sale	—	Aug 09
Form 4	-7.66%	-25.00K	$47.45	-$690.20K	Feb 07, 2006	301.48K	Sale	—	Feb 03
Form 4	-19.90%	-50.00K	$47.89	-$1.25M	Feb 03, 2006	201.25K	Sale	—	Feb 02
Form 4	—	180.00K	—	—	Jan 27, 2006	180.00K	Grant	—	Jan 25
Form 4	—	125.00K	—	—	Jan 28, 2005	125.00K	Grant	—	Jan 26
Form 4	—	250.00K	—	—	Nov 04, 2004	250.00K	Grant	—	Nov 02
Form 3	—	—	—	—	Sep 22, 2004	—	—	—	—

Showing 58 results

Cortexyme, Inc.

Investor

Updated Jun 09, 2020

View Quote Details


Form 4	—	11.03K	—	—	Jun 09, 2020	11.03K	Grant	—	Jun 08
Form 4	—	30.00K	$17.00	$510.00K	Mar 12, 2020	30.00K	Purchase	—	May 13
Form 3	—	—	—	—	May 08, 2019	—	—	—	—

Showing 3 results